"Cardio Metabolic Institute (CMI) is a multi specialty group helping our patients live a longer and healthier life. With a team of board certified cardiologists, pulomonlogist, pain management physician, podiatrist, exercise physiologists, dietitians, behavioral therapists and physical therapists, we help our patients not only with cutting edge diagnostic and therapeutic tools but also help improve their lifestyle to live a healthy and longer life. We are the first and only practice in NJ offering the Pritikin Intensive Cardiac Rehab program. We treat our patients with compassion and the utmost concern and care."

During the past decade, Cardio Metabolic Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardio Metabolic Institute" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cardio Metabolic Institute" are "Cardiovascular Disease" (4 trials), "Heart Failure" (1 trials), "High Cardiovascular Risk" (1 trials), "Hyperlipidemia" (1 trials) and "Iron-deficiency" (1 trials). Many other conditions were trialed in "Cardio Metabolic Institute" in a lesser frequency.

Most popular intervention types in "Cardio Metabolic Institute" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "bococizumab (PF-04950615)" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Ferric Carboxymaltose" (1 trials) and "Lorcaserin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardio Metabolic Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Cardio Metabolic Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cardio Metabolic Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cardio Metabolic Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".